An open-label, multi-center, non-comparative sinus puncture study of 750 mg, short-course levofloxacin in the treatment of acute maxillary sinusitis.
Phase of Trial: Phase III
Latest Information Update: 04 May 2010
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections; Sinusitis
- Focus Therapeutic Use
- 26 May 2009 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.